Gene · 7555
Papers3,135
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 3,135
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of prognosis value and immune microenvironment features of ceRNAs in NSCLC with distinct gene mutation. | Aging (Albany NY) | 2023 | 37390335 | PubTator, text mining | PubMed |
| In vivo dynamics and regulation of DNA G-quadruplex structures in mammals. | Cell Biosci | 2023 | 37381029 | PubTator, text mining | PubMed |
| CD25high Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer. | Cancer Res | 2023 | 37379438 | PubTator, text mining | PubMed |
| NF-κB in Cell Deaths, Therapeutic Resistance and Nanotherapy of Tumors: Recent Advances. | Pharmaceuticals (Basel) | 2023 | 37375731 | PubTator, text mining | PubMed |
| In Cis Effect of DMPK Expanded Alleles in Myotonic Dystrophy Type 1 Patients Carrying Variant Repeats at 5' and 3' Ends of the CTG Array. | Int J Mol Sci | 2023 | 37373276 | PubTator, text mining | PubMed |
| Metabolomics-Guided Identification of a Distinctive Hepatocellular Carcinoma Signature. | Cancers (Basel) | 2023 | 37370840 | PubTator, text mining | PubMed |
| Aedes aegypti and Aedes albopictus (Diptera: Culicidae) ecology, biology, behaviour, and implications on arbovirus transmission in Thailand: Review. | One Health | 2023 | 37363263 | PubTator, text mining | PubMed |
| Endogenous estrogen receptor modulating oxysterols and breast cancer prognosis: Results from the MARIE patient cohort. | Br J Cancer | 2023 | 37355720 | PubTator, text mining | PubMed |
| The cytosolic N-terminal region of heterologously-expressed transmembrane channel-like protein 1 (TMC1) can be cleaved in HEK293 cells. | PLoS One | 2023 | 37352201 | PubTator, text mining | PubMed |
| Effects of Nutrition Education Program for the Japan Diet on Serum Phospholipid Fatty Acid Compositions in Patients with Dyslipidemia: Re-analysis of Data from a Previous Randomized Controlled Trial. | J Atheroscler Thromb | 2023 | 37344446 | PubTator, text mining | PubMed |
| The Potential of Artemisinins as Novel Treatment for Thyroid Eye Disease by Inhibiting Adipogenesis in Orbital Fibroblasts. | Invest Ophthalmol Vis Sci | 2023 | 37326592 | PubTator, text mining | PubMed |
| G-quadruplexes and associated proteins in aging and Alzheimer's disease. | Front Aging | 2023 | 37323535 | PubTator, text mining | PubMed |
| Hypothyroidism and non-alcoholic fatty liver disease: A coincidence or a causal relationship? | World J Hepatol | 2023 | 37305371 | PubTator, text mining | PubMed |
| Perturbations in fatty acid metabolism and collagen production infer pathogenicity of a novel MBTPS2 variant in Osteogenesis imperfecta. | Front Endocrinol (Lausanne) | 2023 | 37305034 | PubTator, text mining | PubMed |
| Signaling pathways and intervention for therapy of type 2 diabetes mellitus. | MedComm (2020) | 2023 | 37303813 | PubTator, text mining | PubMed |
| α-Tocopherol-13'-Carboxychromanol Induces Cell Cycle Arrest and Cell Death by Inhibiting the SREBP1-SCD1 Axis and Causing Imbalance in Lipid Desaturation. | Int J Mol Sci | 2023 | 37298183 | PubTator, text mining | PubMed |
| mTOR Signaling Pathway in Bone Diseases Associated with Hyperglycemia. | Int J Mol Sci | 2023 | 37298150 | PubTator, text mining | PubMed |
| Effects of Dietary Linoleic Acid on Blood Lipid Profiles: A Systematic Review and Meta-Analysis of 40 Randomized Controlled Trials. | Foods | 2023 | 37297374 | PubTator, text mining | PubMed |
| Progesterone signaling in the regulation of luteal steroidogenesis. | Mol Hum Reprod | 2023 | 37289566 | PubTator, text mining | PubMed |
| Metabolic alterations upon SARS-CoV-2 infection and potential therapeutic targets against coronavirus infection. | Signal Transduct Target Ther | 2023 | 37286535 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7555/papers?page=16